Navigation Links
David Smith Named Vice President of Operations for HealthTell
Date:1/10/2013

Chandler, Arizona (PRWEB) January 10, 2013

Dr. Smith will oversee all of HealthTell’s diagnostic chip manufacturing and technical infrastructure development.

“Dr. Smith’s diverse background in biotechnology management and proven execution capabilities give him a unique combination of skills necessary to lead our operations”, said Bill Colston, CEO of HealthTell. “He provides a critical asset in helping us commercialize and provide the enormous economies of scale necessary to meet our business strategy.”

Prior to his new position, Dr. Smith served in senior leadership positions across multiple biotechnology companies, including Affymetrix, 454 Life Sciences, and Codon Devices. A common theme across these companies was Dr. Smith’s ability to transition complex technology from early feasibility to mass production within very short time frames.

Dr. Smith received his BS degree in chemistry from North Central College and his Ph.D. in chemistry from University of Arizona.

About HealthTell

HealthTell, Inc. is an early stage life sciences company focused on providing a service for early screening of cancer and other chronic diseases. HealthTell has developed a unique technology for measuring the “temperature” of an individual’s immune system from a single drop of blood. Similar to how a fever can be used to register the presence of an infection, this assay measures the immune response created by the amplification of billions of antibody molecules in response to specific diseases. HealthTell’s test provides the most specific, early possible detection of disease.

More information about HealthTell is available at http://www.healthtell.com.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10308612.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. DuPont Congratulates David Hula for Highest Overall Yield with Pioneer® hybrid – P2088YHR in 2012 NCGA Corn Yield Contest
2. David Lichtenstein: Biotechnology is Rich Area for Investment
3. Renowned Operations and Supply Chain Expert Dr. David Simchi-Levi Joins OPS Rules
4. Maine Center for Creativity Selects Glenn Close and David Shaw to Receive Inaugural Maine Creative Industry Award
5. China Biologic Products Names Chairman David Gao to Additional Post of CEO
6. Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
7. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
8. Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
9. Law Office of Brodsky & Smith, LLC Announces Investigation of Complete Genomics, Inc.
10. Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters
11. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... control cells — optogenetics — is key to exciting advances in the study ... spatially patterned light projected via free-space optics stimulates small, transparent organisms and excites ...
(Date:12/8/2016)... Mass (PRWEB) , ... December 08, 2016 , ... ... genetic data bioInformatics portal. In response to client demand KbioBox developed a sophisticated ... edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
Breaking Biology Technology:
(Date:12/5/2016)... 5, 2016  The Office of Justice Programs, ... CT Scans Enhance or Replace Medico Legal Autopsies?" ... supporting or replacing forensic autopsies with postmortem X-ray ... In response to recommendations made by The ... CT scans as a potential component of medicolegal ...
(Date:11/29/2016)... 2016 BioDirection, a privately held medical device ... objective detection of concussion and other traumatic brain injury ... a meeting with the U.S. Food and Drug Administration ... Package. During the meeting company representatives reviewed plans for ... to commencement of a planned pilot trial. ...
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):